Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)

OBJECTIVES: To evaluate the long‐term safety (primary objective) and efficacy (secondary objective) of antimuscarinic add‐on therapy in patients receiving mirabegron. METHODS: During a 2‐week screening period, patients (aged ≥20 years, mirabegron treatment for ≥6 weeks, residual overactive bladder s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Osamu, Kakizaki, Hidehiro, Homma, Yukio, Igawa, Yasuhiko, Takeda, Masayuki, Nishizawa, Osamu, Gotoh, Momokazu, Yoshida, Masaki, Yokoyama, Osamu, Seki, Narihito, Okitsu, Akira, Hamada, Takuya, Kobayashi, Akiko, Kuroishi, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles: Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379522/
https://www.ncbi.nlm.nih.gov/pubmed/30548692
http://dx.doi.org/10.1111/iju.13868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379522/
https://www.ncbi.nlm.nih.gov/pubmed/30548692
http://dx.doi.org/10.1111/iju.13868

Ejemplares similares